Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.820
+0.085 (4.90%)
At close: Feb 27, 2026, 4:00 PM EST
1.825
+0.005 (0.27%)
After-hours: Feb 27, 2026, 6:08 PM EST
Equillium Employees
Equillium had 35 employees as of December 31, 2024. The number of employees decreased by 9 or -20.45% compared to the previous year.
Employees
35
Change (1Y)
-9
Growth (1Y)
-20.45%
Revenue / Employee
$125,486
Profits / Employee
-$697,629
Market Cap
110.83M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Agenus | 316 |
| Fortress Biotech | 101 |
| Korro Bio | 87 |
| Biomea Fusion | 42 |
| Vivani Medical | 37 |
| Cassava Sciences | 30 |
| Cognition Therapeutics | 28 |
| iBio, Inc. | 20 |
EQ News
- 3 days ago - Equillium: Multi-Cytokine Platform To Go Beyond Scope Of EQ504 For UC - Seeking Alpha
- 3 days ago - Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference - GlobeNewsWire
- 26 days ago - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Equillium to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update - GlobeNewsWire
- 4 months ago - Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Target and EQ504 Program in Immune-Mediated Diseases Transcript - Seeking Alpha
- 4 months ago - Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025 - GlobeNewsWire
- 5 months ago - Equillium Announces Leadership and Corporate Updates - GlobeNewsWire